Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy

被引:69
|
作者
Gradoni, L
Scalone, A
Gramiccia, M
Troiani, M
机构
[1] Laboratory of Parasitology, Istituto Superiore di Sanità, Rome
[2] Laboratorio di Parassitologia, Istituto Superiore di Sanità, 299-00161 Rome, Viale Regina Elena
关键词
surveillance; leishmaniasis; HIV-1; AIDS;
D O I
10.1097/00002030-199606001-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To actively detect leishmaniasis in HIV-1-infected individuals in Italy, to describe the epidemiological features of the disease in these patients, and to compare them with epidemiological features of leishmaniasis in HIV-negative patients. Design: Retrospective and prospective surveillance study. Patients: Italian patients with HIV-1 infection and leishmaniasis diagnosed between 1985 and 1994. Results: We recorded 116 leishmaniasis cases (115 visceral leishmaniasis), of which 94 (81%) were diagnosed over the last 4 years. Seventy-eight patients (67%) fulfilled the 1993 Centers for Disease Control and Prevention AIDS criteria. Leishmaniasis was passively reported in only 18% of cases. Leishmania incidence estimated among approximately 2700 AIDS patients living leishmaniasis endemic areas averaged 1.6%, with a maximum of 4.9% in Sicily. These rates were up to 500-fold higher than among HIV-negative individuals living in the same areas, and were similar to those of ubiquitous opportunistic agents indicative of AIDS condition. Data from two major endemic regions indicated that overlap of HIV-1 and Leishmania infections has focal characteristics. The occurrence of small case clusters would suggest occasional modes of Leishmania transmission different from the insect vector. The isoenzyme characterization of 38 Leishmania stocks showed a zymodeme spectrum qualitatively and quantitatively different from that of the parasitic agent of visceral leishmaniasis in HIV-negative adults. Conclusions: Active surveillance provided reliable evaluation on the occurrence of HIV-Leishmania coinfections in Italy, although it was limited to hospital-based cases in this study due to general under-reporting of cases. Biological and epidemiological spectrum of the disease suggests that visceral leishmaniasis should be included among AIDS-defining pathologies.
引用
收藏
页码:785 / 791
页数:7
相关论文
共 50 条
  • [21] Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals
    Barcelo, Catalina
    Gaspar, Frederic
    Aouri, Manel
    Panchaud, Alice
    Rotger, Margalida
    Guidi, Monia
    Cavassini, Matthias
    Buclin, Thierry
    Decosterd, Laurent A.
    Csajka, Chantal
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (07) : 1933 - 1942
  • [22] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Kappelhoff, BS
    Huitema, ADR
    Yalvaç, Z
    Prins, JM
    Mulder, JW
    Meenhorst, PL
    Beijnen, JH
    CLINICAL PHARMACOKINETICS, 2005, 44 (08) : 849 - 861
  • [23] Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
    Bregt S. Kappelhoff
    Alwin D. R. Huitema
    Zeynep Yalvaç
    Jan M. Prins
    Jan W. Mulder
    Pieter L. Meenhorst
    Jos H. Beijnen
    Clinical Pharmacokinetics, 2005, 44 : 849 - 861
  • [24] Drug interaction of fluvoxamine and fluoxetine with nevirapine in HIV-1-infected individuals
    de Maat, MM
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    van Gorp, ECM
    Mairuhu, ATA
    Beijnen, JH
    CLINICAL DRUG INVESTIGATION, 2003, 23 (10) : 629 - 637
  • [25] Cytokine Expression During Syphilis Infection in HIV-1-Infected Individuals
    Knudsen, Andreas
    Benfield, Thomas
    Kofoed, Kristian
    SEXUALLY TRANSMITTED DISEASES, 2009, 36 (05) : 300 - 304
  • [26] The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals
    Koks, CHW
    Crommentuyn, KML
    Hoetelmans, RMW
    Burger, DM
    Koopmans, PP
    Mathôt, RAA
    Mulder, JW
    Meenhorst, PL
    Beijnen, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (06) : 631 - 635
  • [27] Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals
    Kappelhoff, BS
    Huitema, ADR
    Yalvaç, Z
    Prins, JM
    Beijnen, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 467 - 467
  • [28] IL-7 as a potential therapy for HIV-1-infected individuals
    Nunnari, G
    Pomerantz, RJ
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (11) : 1421 - 1426
  • [29] Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals
    Aouri, Manel
    Barcelo, Catalina
    Guidi, Monia
    Rotger, Margalida
    Cavassini, Matthias
    Hizrel, Cedric
    Buclin, Thierry
    Decosterd, Laurent A.
    Csajka, Chantal
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (01)
  • [30] Underestimated Amoebic Appendicitis among HIV-1-Infected Individuals in Japan
    Kobayashi, Taiichiro
    Watanabe, Koji
    Yano, Hideaki
    Murata, Yukinori
    Igari, Toru
    Nakada-Tsukui, Kumiko
    Yagita, Kenji
    Nozaki, Tomoyoshi
    Kaku, Mitsuo
    Tsukada, Kunihisa
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (01) : 313 - 320